Strategic Guidelines for Managing Community-Acquired Pneumonia in Immunocompromised Populations Developed
In immunocompromised adults, community-acquired pneumonia should be treated by a multidisciplinary team of physicians.
Infections In Immunocompromised Patients
Risk for Invasive Mold Infections in People with Immunosuppression After Hurricane Harvey
An investigation into mold exposures after Hurricane Harvey demonstrated that immunosuppressed adult residents were exposed to mold and water-damaged areas and many did not wear respiratory protection equipment or other personal protective equipment (PPE), according to a report published in the Morbidity and Mortality Weekly Report. Researchers conducted interviews with a convenience sample of residents…
Type of EBV-Infected Cells Valuable in Diagnosis of Hematologic Disease
Determining the type of cell infected with Epstein-Barr virus (EBV) in peripheral blood mononuclear cells (PBMCs) proves to be a valuable tool for improving the differential diagnosis of hematologic disease with concurrent EBV infection, according to study results published in Open Forum Infectious Diseases. EBV is a herpesvirus that infects approximately 90% of the population…
Worse Outcomes From Legionella Pneumonia in Individuals With Advanced HIV
Previous results stated that Legionella pneumonia characteristics may not differ between individuals with HIV and individuals who do not have HIV.
Oral Vancomycin May Prevent Clostridioides Difficile Infection in Transplant Recipients
Oral vancomycin is effective in preventing C difficile infection in allogeneic hematopoietic cell transplant patients and does not raise the risk for GVHD.
Prognostic Biomarkers to Guide Antibiotic Therapy in Critically Ill Patients
Proadrenomedullin and procalcitonin have demonstrated superiority to C-reactive protein for predicting mortality and guiding antimicrobial therapy in critically ill patients with fever.
RA Treatment During Pregnancy: Is Infection Risk Greater in Offspring?
Children exposed to TNFi’s during the gestational period were found not to have a significantly higher risk of developing serious infections.
Infections Complicating the Use of Monoclonal Antibodies for Malignancy
In this review, David C. Helfgott, MD, editorial advisory board member for Infectious Disease Advisor, focuses on infectious complications from the use of monoclonal antibodies for malignancy.
Fever, Cough, Lobar Consolidation in a Patient Receiving a Biologic
Case of a 51-year-old man with Crohn’s disease who develops fever and cough after receiving biologic treatment.
Infections Complicate Biologic Use in Autoimmune Inflammatory Disorders
The risk for infection and malignancy associated with biologic use complicates the management of patients with a deficient immune system. Equip yourself with the information needed to effectively manage these complex patients.
-
Loading...
-
Loading...
Next post in Infections in Immunocompromised Patients
